Coronavirus

North Rhine-Westphalia’s State Premier Armin Laschet visits future Bayer AG vaccine production site

Bayer to manufacture mRNA vaccine in Germany

CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV

Companies enter into a collaboration and services agreement / Bayer to support CureVac in numerous areas, including development and supply of CVnCoV / CureVac benefits from Bayer´s expertise and established infrastructure / Plan to facilitate the supply of several hundred million doses

Bayer sells a facility at its Wuppertal site to WuXi Biologics

Companies to also enter into long-term sublease agreement and service contract / Buyer planning to use facility to produce COVID-19 vaccine and other biologics